209 related articles for article (PubMed ID: 2066370)
41. Density-dependent changes in the amount of sulfated glycosaminoglycans associated with mouse 3T3 cells.
Underhill CB; Keller JM
J Cell Physiol; 1976 Sep; 89(1):53-63. PubMed ID: 134041
[TBL] [Abstract][Full Text] [Related]
42. Effects of glycosaminoglycans on proliferation of epithelial and fibroblast human malignant mesothelioma cells: a structure-function relationship.
Syrokou A; Tzanakakis G; Tsegenidis T; Hjerpe A; Karamanos NK
Cell Prolif; 1999; 32(2-3):85-99. PubMed ID: 10535355
[TBL] [Abstract][Full Text] [Related]
43. Effect of short- or long-term treatment with exogenous glycosaminoglycans on growth and glycosaminoglycan synthesis of human fibroblasts (WI-38) in culture.
Wever J; Schachtschabel DO; Sluke G; Wever G
Mech Ageing Dev; 1980; 14(1-2):89-99. PubMed ID: 7206818
[TBL] [Abstract][Full Text] [Related]
44. Impaired elastogenesis in Hurler disease: dermatan sulfate accumulation linked to deficiency in elastin-binding protein and elastic fiber assembly.
Hinek A; Wilson SE
Am J Pathol; 2000 Mar; 156(3):925-38. PubMed ID: 10702409
[TBL] [Abstract][Full Text] [Related]
45. Glycosaminoglycans enhance human leukemic cell growth in vitro.
Maurer AM; Han ZC; Dhermy D; Brière J
Leuk Res; 1994 Nov; 18(11):837-42. PubMed ID: 7967710
[TBL] [Abstract][Full Text] [Related]
46. The growth promoter spermine interacts specifically with dermatan sulfate regions that are rich in L-iduronic acid and possess antiproliferative activity.
Belting M; Fransson LA
Glycoconj J; 1993 Dec; 10(6):453-60. PubMed ID: 8173337
[TBL] [Abstract][Full Text] [Related]
47. Differences in the uptake and nuclear localization of anti-proliferative heparan sulfate between human lung fibroblasts and human lung carcinoma cells.
Cheng F; Petersson P; Arroyo-Yanguas Y; Westergren-Thorsson G
J Cell Biochem; 2001; 83(4):597-606. PubMed ID: 11746503
[TBL] [Abstract][Full Text] [Related]
48. The anticoagulant effect of heparan sulfate and dermatan sulfate.
Teien AN; Abildgaard U; Höök M
Thromb Res; 1976 Jun; 8(6):859-67. PubMed ID: 134464
[No Abstract] [Full Text] [Related]
49. Glycosaminoglycans inhibit degradation of insulin-like growth factor-binding protein-5.
Arai T; Arai A; Busby WH; Clemmons DR
Endocrinology; 1994 Dec; 135(6):2358-63. PubMed ID: 7527332
[TBL] [Abstract][Full Text] [Related]
50. Inhibition of rat mesangial cell growth by heparan sulfate.
Groggel GC; Marinides GN; Hovingh P; Hammond E; Linker A
Am J Physiol; 1990 Feb; 258(2 Pt 2):F259-65. PubMed ID: 2137981
[TBL] [Abstract][Full Text] [Related]
51. Heparin potentiates the action of plasma membrane-associated growth stimulatory activity.
Nagasaki T; Lieberman MA
J Cell Physiol; 1987 Nov; 133(2):365-71. PubMed ID: 2445766
[TBL] [Abstract][Full Text] [Related]
52. Heparan sulfate and heparin as a potentiator or a suppressor of growth of normal and transformed vascular endothelial cells.
Imamura T; Mitsui Y
Exp Cell Res; 1987 Sep; 172(1):92-100. PubMed ID: 2958303
[TBL] [Abstract][Full Text] [Related]
53. Adsorption of glycosaminoglycans onto coral--a new possible implant biomaterials for regeneration therapy.
Volpi N
Biomaterials; 1999 Aug; 20(15):1359-63. PubMed ID: 10454006
[TBL] [Abstract][Full Text] [Related]
54. Heparin and related glycosaminoglycans modulate the secretory phenotype of vascular smooth muscle cells.
Majack RA; Bornstein P
J Cell Biol; 1984 Nov; 99(5):1688-95. PubMed ID: 6490716
[TBL] [Abstract][Full Text] [Related]
55. Glycosaminoglycans partially substitute for proteoglycans in spheroid formation of adult rat hepatocytes in primary culture.
Shinji T; Koide N; Tsuji T
Cell Struct Funct; 1988 Apr; 13(2):179-88. PubMed ID: 3383251
[TBL] [Abstract][Full Text] [Related]
56. Accumulation of sulfate-containing acid mucopolysaccharides in I-cell fibroblasts.
Schmickel RD; Distler JJ; Jourdian GW
J Lab Clin Med; 1975 Oct; 86(4):672-82. PubMed ID: 170349
[TBL] [Abstract][Full Text] [Related]
57. The protective effect on Cu2+- and AAPH-mediated oxidation of human low-density lipoproteins depends on glycosaminoglycan structure.
Volpi N; Tarugi P
Biochimie; 1999 Oct; 81(10):955-63. PubMed ID: 10575349
[TBL] [Abstract][Full Text] [Related]
58. Regulation of chondrogenesis by heparan sulfate and structurally related glycosaminoglycans.
San Antonio JD; Winston BM; Tuan RS
Dev Biol; 1987 Sep; 123(1):17-24. PubMed ID: 2957259
[TBL] [Abstract][Full Text] [Related]
59. Effects of heparin and other glycosaminoglycans on elastin production by cultured neonatal rat lung fibroblasts.
McGowan SE; Liu R; Harvey CS
Arch Biochem Biophys; 1993 May; 302(2):322-31. PubMed ID: 8489237
[TBL] [Abstract][Full Text] [Related]
60. Cultured endothelial cells produce a heparinlike inhibitor of smooth muscle cell growth.
Castellot JJ; Addonizio ML; Rosenberg R; Karnovsky MJ
J Cell Biol; 1981 Aug; 90(2):372-9. PubMed ID: 7287812
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
